Endothelial precursor cells home to a vascularized tissue engineering chamber by application of the angiogenic chemokine cxcl12

Tissue Engineering - Part A

Volumn 15, Issue 3, 2009, Pages 655-664

  Simcock, Jeremy W ^a   Penington, Anthony J ^a   Morrison, Wayne A ^a   Thompson, Erik W ^a   Mitchell, Geraldine M ^a  

^a Bernard O'Brien Inst Microsurgery   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANES; EMPLOYMENT; ENDOTHELIAL CELLS; SELF ASSEMBLY; TISSUE;

ADIPOSE TISSUE; CHEMOKINE; CHEMOKINE LIGANDS; IN-VIVO; OSMOTIC PUMPS; PRECURSOR CELLS; PROOF-OF-PRINCIPLE EXPERIMENTS; RECONSTRUCTIVE SURGERY; STROMAL CELLS; VASCULARIZED TISSUES; VASCULATURE;

TISSUE ENGINEERING;

CHEMOTACTIC FACTOR; STROMAL CELL DERIVED FACTOR 1; ANGIOGENIC FACTOR; CD34 ANTIGEN; CXCL1 CHEMOKINE; MESSENGER RNA; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANNULATION; CELL DIFFERENTIATION; CELL HOMING; CELL PROLIFERATION; CELL REGENERATION; CHEMOTAXIS; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; RAT; STEM CELL; TISSUE ENGINEERING; VASCULARIZATION; ANGIOGENESIS; ANIMAL; CELL COUNT; CELL MOTION; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR PATENCY;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; ANTIGENS, CD34; CELL COUNT; CELL MOVEMENT; CHEMOKINE CXCL1; CHEMOKINE CXCL12; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOCYTES; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEM CELLS; TISSUE ENGINEERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR PATENCY;

EID: 64549105764     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2007.0438     Document Type: Article

References (31)

1. Lokmic, Z., Idrizi, R., Messina, A., Knight, K.R., Morrison, W.A., and Mitchell, G.M. Vascularization of engineered constructs. In: Encyclopedia of Biomaterials and Biomedical Engineering. Wnek, G.E., Bowlin, G.L. (eds.) New York: Marcel Dekker Inc., 2004, pp. 1750-1759.
2. Mian, R., Morrison, W.A., Hurley, J.V., Penington, A.J., Romeo, R., Tanaka, Y., and Knight, K.R. Formation of new tissue from an arteriovenous loop in the absence of added extracellular matrix. Tissue Eng 6, 595-603, 2000.
3. Hofer, S.O., Knight, K.M., Cooper-White, J.J., O'Connor, A.J., Perera, J.M., Stevens, G.W., Penington, A.J., Knight, K.R., Morrison, W.A., and Messina, A. Increasing the volume of vascularized tissue formation in engineered constructs: an experimental study in rats. Plast Reconstr Surg Mar 111,1186-1192; discussion 1193-1194, 2003.
4. Tanaka, Y., Sung, K.C., Tsutsumi, A., Ohba, S., Ueda, K., and Morrison, W.A. Tissue engineering skin flaps: which vascular carrier, arteriovenous shunt loop or arteriovenous bundle, has more potential for angiogenesis and tissue generation? Plast Reconstr Surg 112, 1636-1644, 2003.
5. Lokmic, Z., Stillaert, F., Morrison, W.A., Thompson, E.W., and Mitchell, G.M. An arteriovenous loop in a protected space generates a permanent, highly vascular, tissueengineered construct. FASEB J 21, 511-522, 2007.
6. Juarez, J., Bendall, L., and Bradstock, K. Chemokines and their receptors as therapeutic targets: the role of the SDF-1/CXCR4 axis. Curr Pharm Des 10, 1245-1259, 2004.
7. Salcedo, R., and Oppenheim, J.J. Role of chemokines in angiogenesis: CXCL12/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses. Microcirculation 10,359-370, 2003.
8. Salcedo, R., Wasserman, K., Young, H.A., Grimm, M.C., Howard, O.M., Anver,M.R., Kleinman, H.K., Murphy,W.J., and Oppenheim, J.J. Vascular endothelial growth factor and basic fibroblast growth factor induce expression ofCXCR4 on human endothelial cells: in vivo neovascularization induced by stromalderived factor-1alpha. Am J Pathol 154, 1125-1135, 1999.
9. Asahara, T., and Kawamoto, A. Endothelial progenitor cells for postnatal vasculogenesis. Am J Physiol Cell Physiol 287,C572-C579, 2004.
10. Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., and Isner, J.M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964-967, 1997.
11. Ceradini, D.J., Kulkarni, A.R., Callaghan, M.J., Tepper, O.M., Bastidas, N., Kleinman, M.E., Capla, J.M., Galiano, R.D., Levine, J.P., and Gurtner, G.C. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10, 858-864, 2004.
12. De Falco, E., Porcelli, D., Torella, A.R., Straino, S., Iachininoto, M.G., Orlandi, A., Truffa, S., Biglioli, P., Napolitano, M., Capogrossi, M.C., and Pesce, M. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 104, 3472-3482, 2004.
13. + progenitors increases their proliferation, migration, and NOD/SCID repopulation. Blood 103: 2942-2949, 2004.
14. Kayali, A.G., Van Gunst, K., Campbell, I.L., Stotland, A., Kritzik, M., Liu, G., Flodström-Tullberg, M., Zhang, Y.Q., and Sarvetnick, N. The stromal cell-derived factor-1alpha/CXCR4 ligand-receptor axis is critical for progenitor survival and migration in the pancreas. J Cell Biol 163, 859-869, 2003.
15. Lapidot, T., and Petit, I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 30, 973-981, 2002.
16. + cell-derived endothelial progenitor cell transplantation. Thromb Haemost 91, 1202-1212, 2004.
17. Scherle, W. A simple method for volumetry of organs in quantitative stereology. Mikroskopie 26, 57-60, 1970.
18. Kocher, A.A., Schuster, M.D., Szabolcs, M.J., Takuma, S., Burkhoff, D., Wang, J., Homma, S., Edwards, N.M., and Itescu, S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7, 430-436, 2001.
19. Tester, A.M., Sharp, J.A., Dhanesuan, N., Waltham, M., and Thompson, E.W. Correlation between extent of osteolytic damage and metastatic burden of human breast cancer metastasis in nude mice: real-time PCR quantitation. Clin Exp Metastasis 19, 377-383, 2002.
20. Howard, C., and Reed, M. Unbiased Stereology: Bios. Oxford, UK: Scientific Publishers, 1998.
21. Lokmic, Z., Darby, I.A., Thompson, E.W., and Mitchell, G.M. Time course analysis of hypoxia, granulation tissue and blood vessel growth, and remodeling in healing rat cutaneous incisional primary intention wounds. Wound Repair Regen 14, 277-288, 2006.
22. Wu, C.H., Chien, H.F., Chang, C.Y., and Ling, E.A. Heterogeneity of antigen expression and lectin labeling on microglial cells in the olfactory bulb of adult rats. Neurosci Res 28, 67-75, 1997.
23. Hitchon, C., Wong, K., Ma, G., Reed, J., Lyttle, D., and El-Gabalawy, H. Hypoxia-induced production of stromal cellderived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts. Arthritis Rheum 46, 2587-2597, 2002.
24. Suratt, B.T., Petty, J.M., Young, S.K., Malcolm, K.C., Lieber, J.G., Nick, J.A., Gonzalo, J.A., Henson, P.M., and Worthen, G.S. Role of the CXCR4/SDF-1 chemokine axis in circulating neutrophil homeostasis. Blood 104, 565-571, 2004.
25. Peled, A., Kollet, O., Ponomaryov, T., Petit, I., Franitza, S., Grabovsky, V., Slav, M.M., Nagler, A., Lider, O., Alon, R., Zipori, D., and Lapidot, T. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood 95, 3289-3296, 2000.
26. Murdoch, C., and Finn, A. Chemokine receptors and their role in vascular biology. J Vasc Res 37, 1-7, 2000.
27. Romagnani, P., Lasagni, L., Annunziato, F., Serio, M., and Romagnani, S. CXC chemokines: the regulatory link between inflammation and angiogenesis. Trends Immunol 25,201-209, 2004.
28. McCourt, M., Wang, J.H., Sookhai, S., and Redmond, H.P. Proinflammatory mediators stimulate neutrophil-directed angiogenesis. Arch Surg 134, 1325-1332, 1999.
29. Carmeliet, P. Manipulating angiogenesis in medicine. J Intern Med 255, 538-561, 2004.
30. Hofer, S.O.P., Mitchell, G.M., Penington, A.J., Morrison, W.A., Romeo-Meeuw, R., Keramidaris, E., and Knight, K.R. The use of pimonidazole to characterize hypoxia in the internal environment of an in vivo tissue engineering chamber. Br J Plast Surg 58, 1104-1114, 2005.
31. Yamaguchi, J., Kusano, K.F., Masuo, O., Kawamoto, A., Silver, M., Murasawa, S., Bosch-Marce, M., Masuda, H., Losordo, D.W., Isner, J.M., and Asahara, T. Stromal cellderived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107, 1322-1328, 2003.